Briët E, van der Meer F W, van Dijk-van Kempen C J, Schmidt P H, Otten F W, Meyer K, Broekmans A W
Acta Haematol. 1985;73(2):97-100. doi: 10.1159/000206289.
The sequential use of human and porcine factor VIII for the treatment of a patient with a moderately high titre (38 Bethesda units) factor VIII inhibitor enabled us to provide adequate haemostatic cover for 17 days. In this period a pleomorphic adenoma of the parotid gland was removed. Bleeding did not occur and wound healing was uneventful.